Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines.

MLA

Chen, Li, et al. “Co-Delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines.” AAPS PharmSciTech, vol. 20, no. 3, Feb. 2019, p. 99. EBSCOhost, https://doi.org/10.1208/s12249-019-1316-0.

APA

Chen, L., Alrbyawi, H., Poudel, I., Arnold, R. D., & Babu, R. J. (2019). Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines. AAPS PharmSciTech, 20(3), 99. https://doi.org/10.1208/s12249-019-1316-0

Chicago

Chen, Li, Hamad Alrbyawi, Ishwor Poudel, Robert D Arnold, and R Jayachandra Babu. 2019. “Co-Delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines.” AAPS PharmSciTech 20 (3): 99. doi:10.1208/s12249-019-1316-0.